12 completed, 4 recruiting, 2 not yet recruiting, 2 terminated. 24 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 24 | Completed 12, Recruiting 4, Not yet recruiting 2, Terminated 2, Unknown 2, Withdrawn 2 |
Follow Malaria, Vivax: new trials by email Literature Review of Malaria, Vivax trials Research Report on Malaria, Vivax
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tafenoquine and ACTs (TADORE- Plus) Tafenoquine plus DHA-Piperaquine, Tafenoquine plus Artesunate-pyronaridine - Vivax Malaria | Phase 4 | Not yet recruiting | Menzies School of Health Research | 507 | 2026-06-01 | 2026-03-18 |
| Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria Single dose tafenoquine (10 mg/kg), Dihydroartemisinin-piperaquine (DHA-PPQ), Artemether + Lumefantrine - Uncomplicated Malaria | Phase 4 | Not yet recruiting | Curtin University | 60 | 2026-04-01 | 2026-02-12 |
| Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children Single dose tafenoquine (10 mg/kg) given with water, Single dose tafenoquine (10 mg/kg) given with fat - Pharmacokinetics of Tafenoquine | Phase 4 | Recruiting | Curtin University | 30 | 2025-10-20 | 2026-03-18 |
| Vivax Elimination With Tafenoquine (VET) Study Tafenoquine - Malaria, Malaria, Vivax | Phase 4 | Completed | Shoklo Malaria Research Unit | 1242 | 2025-02-19 | 2026-01-06 |
| Southeast Asia Dose Optimization of Tafenoquine Tafenoquine, Chloroquine, Artemether 20 mg-Lumefantrine 120 mg - Plasmodium Vivax Malaria | Phase 4 | Recruiting | University of Oxford | 820 | 2024-07-22 | 2026-10-09 |
| Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases. Patients with G6PD enzyme activities between 30 and <70% of the AMM will be treated with schizontocidal treatment plus high dose primaquine 1mg/kg/day for 7 days, Patients with G6PD enzyme activities <30% of the AMM will be treated with schizontocidal treatment plus 8 weekly primaquine (0.75mg/kg dose). - Vivax Malaria, G6PD Deficiency | Phase 4 | Recruiting | Menzies School of Health Research | 100 | 2024-05-17 | 2026-03-12 |
| Tafenoquine and Primaquine in Colostrum and Breast Milk Primaquine, Tafenoquine - Healthy Lactating Women | Phase 4 | Withdrawn | University of Oxford | 2023-07-01 | 2024-04-04 | |
| ACT vs CQ With Tafenoquine for P. Vivax Mono-infection Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose), Chloroquine plus Tafenoquine (450 mg adult dose), Artemether-Lumefantrine plus Tafenoquine (450 mg adult dose) - Malaria, Malaria, Vivax | Phase 4 | Recruiting | Shoklo Malaria Research Unit | 606 | 2023-06-26 | 2025-05-16 |
| Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax Chloroquine, Primaquine - Efficacy, Malaria | Phase 4 | Completed | Dinka Dugassa | 100 | 2022-12-19 | 2023-09-22 |
| Short Course Radical Cure of P. Vivax Malaria in Nepal primaquine - Malaria, Malaria, Vivax | Phase 4 | Completed | Menzies School of Health Research | 27 | 2021-10-27 | 2024-08-29 |
| Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure Primaquine, Artesunate - Vivax Malaria | Phase 4 | Completed | University of Maryland, Baltimore | 160 | 2021-04-15 | 2026-06-03 |
| Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas primaquine - Malaria, Vivax Malaria | Phase 4 | Completed | Menzies School of Health Research | 500 | 2019-08-18 | 2023-11-21 |
| Assessing a Risk Model for G6PD Deficiency primaquine, chloroquine + primaquine - Malaria, Vivax, G6PD Deficiency | Phase 4 | Terminated | PATH | 54 | 2018-05-07 | 2021-11-12 |
| G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria Chloroquine, Primaquine 0.25 mg/kg/day, Primaquine 0.75 mg/kg weekly - Vivax Malaria | Phase 4 | Completed | University of Oxford | 1000 | 2016-09-01 | 2020-10-14 |
| Evaluating the Efficacy of Chloroquine for the Treatment of Plasmodium Vivax Infections in Central Vietnam Chloroquine - Plasmodium Vivax | Phase 4 | Unknown | National Institute of Malariology, Parasitology and Entomology, Vietnam | 100 | 2015-03-01 | 2016-03-23 |
| Assessment of Plasmodium Vivax Chloroquine Resistance in Cambodia: Chloroquine sulfate, DHA-PP - Vivax Malaria | Phase 4 | Completed | Institut Pasteur, Cambodia | 73 | 2014-05-01 | 2015-03-24 |
| Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam Chloroquine, Dihydroartemisinin/Piperaquine - Plasmodium Vivax Malaria | Phase 4 | Completed | Oxford University Clinical Research Unit, Vietnam | 330 | 2013-02-01 | 2016-09-30 |
| Ethiopia Antimalarial in Vivo Efficacy Study 2012 Artemether-lumefantrine combination, Primaquine, Chloroquine - Plasmodium Vivax Infection | Phase 4 | Completed | Centers for Disease Control and Prevention | 398 | 2012-10-01 | 2017-01-19 |
| Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Vivax in Pregnancy in Brazil (PAACT-PV) Mefloquine- Artesunate, Artemether-Lumefantrine, Chloroquine - Plasmodium Vivax Malaria | Phase 4 | Terminated | Centers for Disease Control and Prevention | 16 | 2011-02-01 | 2012-04-13 |
| Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection Primaquine - Plasmodium Vivax | Phase 4 | Unknown | Papua New Guinea Institute of Medical Research | 150 | 2010-06-01 | 2015-10-14 |
Showing 20 of 24. Sign in to see all of them.
Malaria (11) · Malaria, Falciparum (3) · Recurrence (3) · Glucosephosphate Dehydrogenase Deficiency (2)
Infections (24) · Mosquito-Borne Diseases (24) · Parasitic Diseases (24) · Protozoan Infections (24) · Vector Borne Diseases (24) · Malaria (13) · Disease Attributes (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Anemia (2) · Anemia, Hemolytic (2) · Anemia, Hemolytic, Congenital (2) · Carbohydrate Metabolism, Inborn Errors (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2)
Primaquine (14) · Chloroquine (13) · tafenoquine (7) · Artemether, Lumefantrine Drug Combination (5) · artenimol (2) · chloroquine diphosphate (2) · piperaquine (2) · 2,6-diisopropylphenol docosahexaenoate (1) · Artemether (1) · Artesunate (1) · CD36 Antigens (1) · Lumefantrine (1) · Water (1) · lactitol (1) · pyronaridine tetraphosphate, artesunate drug combination (1)
Menzies School of Health Research (4) · University of Oxford (4) · Centers for Disease Control and Prevention (2) · Curtin University (2) · Papua New Guinea Institute of Medical Research (2) · Shoklo Malaria Research Unit (2) · Dinka Dugassa (1) · Institut Pasteur, Cambodia (1) · Institut de Recherche pour le Developpement (1) · LILIA GONZALEZ CERON (1) · National Institute of Malariology, Parasitology and Entomology, Vietnam (1) · Oxford University Clinical Research Unit, Vietnam (1) · PATH (1) · University of Maryland, Baltimore (1)
Papua New Guinea (5) · Thailand (5) · Ethiopia (4) · Cambodia (3) · Vietnam (3) · Afghanistan (2) · Brazil (2) · Indonesia (2) · Bangladesh (1) · Laos (1) · Nepal (1)
Brioni R Moore, PhD (2) · Ivo Mueller, PhD (2) · Anna Rosanas-Urgell, MD, PhD (1) · Bockretsion Gidey (1) · Cindy Chu, MD, PhD (1) · David Hoos, MD MPH (1) · Duong Tran, MD, PhD (1) · Dysoley Lek, MD (1) · Francois Nosten, Prof (1) · Ghulam Rahim Awab, MD (1) · Inoni Betuela, MD PhD (1) · Inoni Betuela, MD, PhD (1)
PMID 22531245, PMID 23212366, PMID 26505753, PMID 26518132, PMID 28510573, PMID 28732068, PMID 28862132, PMID 29362233, PMID 29398388, PMID 30698522, PMID 33299558, PMID 33552517, PMID 34031050, PMID 34336132, PMID 35585641, PMID 36099312, PMID 36534705, PMID 37269941, PMID 37790581, PMID 37979594, PMID 38115002, PMID 39802788, PMID 40112852, PMID 40764298, PMID 42033147, PMID 42439801
R01AI103228 (1)